• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:舒成仁,黄露,邓彬.阿莫西林克拉维酸钾胶囊的生物等效性研究[J].中国现代应用药学,2012,29(5):454-457.
SHU Chengren, HUANG Lu, DENG Bin.Bioequivalence of Amoxicillin Sodium and Clavutante Potassium Capsules in Chinese Healthy Volunteers[J].Chin J Mod Appl Pharm(中国现代应用药学),2012,29(5):454-457.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2500次   下载 2570 本文二维码信息
码上扫一扫!
分享到: 微信 更多
阿莫西林克拉维酸钾胶囊的生物等效性研究
舒成仁,黄露,邓彬1,2
1.湖北省黄石市中心医院,湖北 黄石435000;2.武汉市第六医院药剂科,武汉 430015
摘要:
目的 研究两种阿莫西林克拉维酸钾胶囊的生物等效性。方法 采用2制剂2周期自身对照交叉试验设计,利用高效液相色谱-串联质谱法测定血浆中阿莫西林和克拉维酸钾药物浓度。结果 受试胶囊和参比胶囊中阿莫西林的AUC0→10分别为(19.132±4.196),(19.001±4.076)mg·h·mL-1;AUC0→∞分别为(19.376±4.197),(19.301±4.086)mg·h·mL-1Cmax分别为(6.294±1.819),(6.293±1.973)mg·mL-1Tmax分别为(2.000±0.585),(2.100±0.447)h;克拉维酸钾的AUC0→10分别为(4.333±2.317),(4.275±2.231)mg·h·mL-1;AUC0→∞分别为(4.383±2.320),(4.320±2.236)mg·h·mL-1Cmax分别为(1.722±0.961),(1.623±0.813)mg·mL-1Tmax分别为(1.850±0.651),(1.950±0.647)h;两制剂的阿莫西林和克拉维酸钾的相对生物利用度分别为(101.8±14.8)%,(112.5±62.0)%。结论 两种胶囊具生物等效性。
关键词:  阿莫西林克拉维酸钾胶囊  相对生物利用度  生物等效性  高效液相色谱-串联质谱法
DOI:
分类号:
基金项目:
Bioequivalence of Amoxicillin Sodium and Clavutante Potassium Capsules in Chinese Healthy Volunteers
SHU Chengren, HUANG Lu, DENG Bin1,2
1.Pharmacy Department of Huangshi Central Hospital, Huangshi 435000, China;2.Pharmacy Department of The 6th Hospital of Wuhan City, Wuhan 430015, China
Abstract:
OBJECTIVE To evaluate the bioequivalence of Amoxicillin sodium and Clavutante Potassium capsules in Chinese healthy volunteers. METHODS Concentrations of Amoxicillin sodium and Clavutante Potassium in plasma were determined by HPLC/MS/MS after healthy volunteers received a single dose of test dispersible capsule and reference capsule in two-treatment, two-period, crossover design. RESULTS The main pharmacokinetic parameters of Amoxicillin sodium and Clavutante Potassium capsules were as follows: AUC0→10 (Amoxicillin) were (19.132±4.196) and (19.001±4.076)mg·h·mL-1; AUC0→∞(Amoxicillin) were (19.376±4.197) and (19.301±4.086)mg·h·mL-1; Cmax(Amoxicillin) were (6.294±1.819) and (6.293±1.973)mg·mL-1; Tmax(Amoxicillin) were (2.000±0.585) and (2.100±0.447)h; AUC0→10(Clavutante) were (4.333±2.317) and (4.275±2.231)mg·h·mL-1;AUC0→∞(Clavutante) were (4.383±2.320) and (4.320±2.236)mg·h·mL-1; Cmax(Clavutante) were (1.722±0.961) and (1.623±0.813)mg·mL-1; Tmax(Clavutante) were (1.850±0.651) and (1.950±0.647)h; The relative bioavailability of Amoxicillin sodium and Clavutante Potassium were (101.8±14.8)% and (112.5±62.0)%. CONCLUSION The results of statistic analysis show that two capsules of Amoxicillin sodium and Clavutante Potassium were bioequivalent.
Key words:  Amoxicillin sodium and Clavutante Potassium capsules  relative bioavailability  bioequivalence  HPLC/MS/MS
扫一扫关注本刊微信